Chronic hepatitis C ICD11 code: 1E91.1
Core pangenotypic when used in combination with sofosbuvir.
Oral > Solid: 30 mg tablet (as hydrochloride) ; 60 mg tablet (as hydrochloride)
Adolescents and adults
Summary of evidence and Expert Committee recommendations
The listing for daclatasvir was qualified by a note indicating that it is pangenotypic when used in combination with sofosbuvir. Pangenotypic direct acting antivirals are considered therapeutically equivalent for the purposes of selection and procurement at national level.